Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H22N2O2S.ClH |
| Molecular Weight | 366.905 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(CN(C)C)CN1C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C13
InChI
InChIKey=NPMMOYKGIWLASW-UHFFFAOYSA-N
InChI=1S/C18H22N2O2S.ClH/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)23(21,22)18-11-7-5-9-16(18)20;/h4-11,14H,12-13H2,1-3H3;1H
| Molecular Formula | C18H22N2O2S |
| Molecular Weight | 330.444 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Extractive spectrophotometric methods for the determination of oxomemazine hydrochloride in bulk and pharmaceutical formulations using bromocresol green, bromocresol purple and bromophenol blue. | 2005 Apr |
|
| Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells. | 2005 Nov-Dec |
|
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
Sample Use Guides
Oxomemazine 0.33 mg/ml syrup.
Suitable for adults and children over 40 kg (from the age of 12 years old).
10 ml 4 times per day.
For children:
The daily dose according to a child’s weight (1ml of syrup per kg per day):
· Child between 13-20 kg (between 2-6 years old): 5ml 2-3 times per day.
· Child between 20-30 kg (between 6-10 years old): 10 ml 2-3 times per day.
· Child between 30-40 kg (between 10-12 years old): 10 ml 3-4 times a day.
Repeat if necessary minimum every 4 hours.
Due to the sedative effect of oxomemazine it is advisable to take this medication in the evening.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:31:45 GMT 2023
by
admin
on
Sat Dec 16 10:31:45 GMT 2023
|
| Record UNII |
6BOK44G9K6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
13718-11-1
Created by
admin on Sat Dec 16 10:31:45 GMT 2023 , Edited by admin on Sat Dec 16 10:31:45 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
4784-40-1
Created by
admin on Sat Dec 16 10:31:45 GMT 2023 , Edited by admin on Sat Dec 16 10:31:45 GMT 2023
|
PRIMARY | |||
|
SUB21934
Created by
admin on Sat Dec 16 10:31:45 GMT 2023 , Edited by admin on Sat Dec 16 10:31:45 GMT 2023
|
PRIMARY | |||
|
100000085209
Created by
admin on Sat Dec 16 10:31:45 GMT 2023 , Edited by admin on Sat Dec 16 10:31:45 GMT 2023
|
PRIMARY | |||
|
3083870
Created by
admin on Sat Dec 16 10:31:45 GMT 2023 , Edited by admin on Sat Dec 16 10:31:45 GMT 2023
|
PRIMARY | |||
|
6BOK44G9K6
Created by
admin on Sat Dec 16 10:31:45 GMT 2023 , Edited by admin on Sat Dec 16 10:31:45 GMT 2023
|
PRIMARY | |||
|
DTXSID2048612
Created by
admin on Sat Dec 16 10:31:45 GMT 2023 , Edited by admin on Sat Dec 16 10:31:45 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |